Garonit Pharmaceuticals Private Limited
About Garonit Pharmaceuticals Private Limited
Data last updated:
Garonit Pharmaceuticals Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021FTC355132.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Rohit Shamlal Garg and Nitin Sham Lal Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 305 Vip Plaza Off Link Road Andheri West Veera Desai R Opp. Infinity Mall, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.5 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹6.6 Lakh (net margin -439.2%) and EBITDA of -₹5.86 Lakh (EBITDA margin -389.8%).
Company details
Contact details
Garonit Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA – 305 Vip Plaza Off Link Road Andheri West Veera Desai R Opp. Infinity Mall, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Garonit Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Garonit Pharmaceuticals Private Limited
FY 2025 filings availableGaronit Pharmaceuticals Private Limited reported revenue of ₹1.5 Lakh (down 78% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 78% in the latest year. EBITDA fell 187% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -389.8% | ||||
| Net Profit Margin | -439.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Garonit Pharmaceuticals Private Limited, buy the company report.
Board of directors of Garonit Pharmaceuticals Private Limited
Garonit Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Shamlal Garg Also directs: R.N. Laboratories Private Limited | Director | 22 Feb 2022 | 4 Years 8 Months | Current |
| Nitin Sham Lal Garg Also directs: R.N. Laboratories Private Limited, Neelam Garg Foundation | Director | 11 Feb 2021 | 5 Years 8 Months | Current |
| Darshan Harish Bhawsar Also directs: R.N. Laboratories Private Limited, Neelam Garg Foundation | Director | 05 Mar 2025 | 1 Years 7 Months | Current |
| Vijay Nilkanth Koyande | Additional Director | 29 Sep 2025 | 1 Years 0 Months | Current |
Peer comparison
Garonit Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cadmed Pharmaceuticals Private Limited | ₹1.52 Lakh (FY 2022) | -94.0% | Delhi, India | |||
| Ryptomed Pharmaceuticals Private Limited | ₹1.52 Lakh (FY 2021) | Indore, Madhya Pradesh, India | ||||
| PBL Pharmaceuticals Private Limited | ₹1.51 Lakh (FY 2020) | 19.0% | Rudrapur, Uttarakhand, India | |||
| Spichemis Pharmaceuticals Private Limited | ₹1.51 Lakh (FY 2025) | 244.0% | Hyderabad, Telangana, India | |||
| Anrgs Pharmaceuticals Private Limited | ₹1.5 Lakh (FY 2025) | 28.0% | Patna, Bihar, India | |||
| Garonit Pharmaceuticals Private Limitedthis company | ₹1.5 Lakh (FY 2025) | -₹6.6 Lakh | -439.2% | -78.0% | Mumbai, Maharashtra, India | |
| Dattatreya Pharmaceuticals Private Limited | ₹1.5 Lakh (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Sevya Pharmaceuticals Private Limited | ₹1.5 Lakh (FY 2024) | 1761.0% | Old Faridabad, Haryana, India | |||
| Osiria Pharmaceuticals Private Limited | ₹1.5 Lakh (FY 2024) | -98.0% | Bhubaneswar, Odisha, India | |||
| Molicule Pharmaceuticals Private Limited | ₹1.49 Lakh (FY 2018) | -65.0% | Cuttack, Odisha, India | |||
| Lifeshine Pharmaceuticals Private Limited | ₹1.48 Lakh (FY 2023) | 14.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Garonit Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Garonit Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Garonit Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Garonit Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
No GST registration is on our record for Garonit Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Garonit Pharmaceuticals Private Limited has 7 board changes on record since 2021: 5 appointments and 2 cessations. The latest: Vijay Nilkanth Koyande was appointed as Additional Director on 29 Sep 2025.
Frequently asked questions
Garonit Pharmaceuticals is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2021 (5+ years old) and is registered under CIN U24290MH2021FTC355132.
Garonit Pharmaceuticals has 4 current directors:
- Rohit Shamlal Garg - Director
- Nitin Sham Lal Garg - Director
- Darshan Harish Bhawsar - Director
- Vijay Nilkanth Koyande - Additional Director
The latest financial statements of Garonit Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Garonit Pharmaceuticals is U24290MH2021FTC355132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Garonit Pharmaceuticals was incorporated on 11 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Garonit Pharmaceuticals by revenue are Cadmed Pharmaceuticals Private Limited, Ryptomed Pharmaceuticals Private Limited, PBL Pharmaceuticals Private Limited, Spichemis Pharmaceuticals Private Limited, Anrgs Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Vijay Nilkanth Koyande was appointed as Additional Director on 29 Sep 2025. Darshan Harish Bhawsar was appointed as Director on 05 Mar 2025. Sanket Dhondiraj Sawant was appointed as Additional Director on 24 Dec 2024. Garonit Pharmaceuticals has 7 board changes on record in total.
The registered office of Garonit Pharmaceuticals is at A – 305 Vip Plaza Off Link Road Andheri West Veera Desai R Opp. Infinity Mall, Mumbai, Maharashtra, India – 400053.
Garonit Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Garonit Pharmaceuticals can be reached at its registered office: A – 305 Vip Plaza Off Link Road Andheri West Veera Desai R Opp. Infinity Mall, Mumbai, Maharashtra, India – 400053.
Garonit Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.